Search Press releases Keywords From To 4 Dec 2023 UCB announces European Commission approval of ZILBRYSQ[®]▼ (zilucoplan) for the treatment of adults with generalized Myasthenia Gravis Read More 1 Dec 2023 UCB presents new data advancing patient-focused scientific leadership at American Epilepsy Society Annual Meeting Read More 23 Nov 2023 Transparency notification Wellington Read More 16 Nov 2023 ‘Rheumacensus’ experts unite and call for essential psoriatic arthritis and axial spondyloarthritis care improvements Read More 11 Nov 2023 Post hoc analysis showed meaningful efficacy of certolizumab pegol for RA patients with high Rheumatoid Factor (RF) levels Read More 10 Nov 2023 UCB receives CHMP positive opinion for rozanolixizumab for treatment of adults with generalized myasthenia gravis in Europe Read More Pagination First page Previous page Previous … Page 15 Page 16 Page 17 Page 18 Current page 19 Page 20 Page 21 Page 22 Page 23 … Page 19 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
